Search Within

Tiffany A Traina

Formats
  1. Meeting Abstract (140)
  2. Journal Article (95)
  3. Book Section (8)
  4. Review (6)
  5. Book Whole (2)
  6. Guidelines (1)
  7. Miscellaneous (1)
Groups
  1. Breast Medicine Service (253)
  2. Department of Medicine (253)
  3. Solid Tumor Oncology Division (253)
  4. Survivorship Research (253)
  5. Epidemiology and Biostatistics (101)
  6. Biostatistics Service (87)

More Groups

People
  1. Clifford Hudis (95)
  2. Sujata Patil (62)
  3. Ayca Gucalp (59)
  4. Larry Norton (56)
  5. Maura Dickler (34)
  6. Diana Lake (33)

More People

Years
  1. 2025 (6)
  2. 2024 (16)
  3. 2023 (8)
  4. 2022 (13)
  5. 2021 (17)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (79)
  2. Cancer Research (44)
  3. Breast Cancer Research and Treatment (16)
  4. Annals of Oncology (14)
  5. Clinical Cancer Research (11)
  6. Clinical Breast Cancer (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (80)
  2. American Association for Cancer Research (55)
  3. Springer (33)
  4. Elsevier Inc. (23)
  5. Oxford University Press (16)
  6. Future Medicine (5)

More Publishers

Results (253)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • IBL2001: Phase (ph) I/II study of a novel dose-dense (dd) schedule of indibulin for the treatment of metastastic breast cancer
    Meeting Abstract

    Traina, T. A.; Hudis, C.; Gonzalez, J.; Anthony, S. P.; Smith, D. A.; Chandler, J. C.; Jac, J.; Youssoufian, H.; Norton, L.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase II, single-arm, feasibility study of dose-dense doxorubicin and cyclophosphamide (AC) followed by eribulin mesylate for the adjuvant treatment of early-stage breast cancer (EBC)
    Meeting Abstract

    Traina, T. A.; Hudis, C.; Lehman, R.; Rege, J.; Wang, W.; Cox, D.; Seidman, A. D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A translational study to investigate the association between smoking-induced lung inflammation and lung metastases (LM) from breast cancer (BC)
    Meeting Abstract

    Morris, P. G.; Zhou, X. K.; Milne, G. L.; Goldstein, D. A.; Hawks, L.; Uzunaslan, D.; Dang, C. T.; Keenan, K.; Modi, S.; Fornier, M. N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • MDV3100-08: A phase I open-label, dose-escalation study evaluating the safety, tolerability, and pharmacokinetics of MDV3100 in women with incurable breast cancer
    Meeting Abstract

    Elias, A. D.; Richer, J. K.; LoRusso, P.; Peterson, A. C.; Steinberg, J. L.; Mordenti, J.; Lopez, C.; Hudis, C.; Traina, T. A.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Norton-Simon modeling for the optimization of dose and schedule of palifosfamide in breast cancer
    Meeting Abstract

    Traina, T. A.; Hudis, C.; Lewis, J.; Norton, L.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Adjuvant treatment of early-stage breast cancer with eribulin mesylate following dose-dense doxorubicin and cyclophosphamide: Preliminary results from a phase 2, single-arm feasibility study
    Meeting Abstract

    Traina, T. A.; Hudis, C.; Fornier, M.; Lake, D.; Lehman, R.; Berkowitz, A. P.; Rege, J.; Liao, J.; Cox, D.; Seidman, A. D.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • IBL2001: Phase I/II study of a novel dose-dense schedule of oral indibulin for the treatment of metastastic breast cancer
    Meeting Abstract

    Traina, T. A.; Hudis, C.; Seidman, A.; Gajria, D.; Gonzalez, J.; Anthony, S. P.; Smith, D. A.; Chandler, J. C.; Jac, J.; Youssoufian, H.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Impact of BRCA1/2 mutation status in TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple negative breast cancer
    Meeting Abstract

    Isakoff, S. J.; Goss, P. E.; Mayer, E. L.; Traina, T.; Carey, L. A.; Krag, K. J.; Liu, M. C.; Rugo, H.; Stearns, V.; Come, S.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Evaluation of the prognostic significance of androgen receptor (AR) expression in relation to ER expression in breast cancer (BC)
    Meeting Abstract

    Gucalp, A.; Datko, F. M.; Patil, S.; Hedvat, C. V.; Kalinsky, K.; Hudis, C. A.; Traina, T. A.; Moynahan, M. E.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Endocrine biomarkers in response to AR-inhibition with bicalutamide for the treatment of AR(+), ER/PR(-) metastatic breast cancer (MBC) (TBCRC011)
    Meeting Abstract

    Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J.; Liu, M. C.; Carey, L.; Blackwell, K. L.; Rugo, H.; Nabell, L.; Forero, A.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save